[Ip-health] Public Citizen Submissions on HHS WHA listening session, and House Oversight Committee Hearing on PrEP

Zain Rizvi zrizvi at citizen.org
Tue May 21 08:08:59 PDT 2019

Hi everyone,

Please see below for two recent submissions made by Public Citizen:

  1.  On May 6, 2019, the U.S. Department of Health & Human Services held a stakeholder listening session to help inform the U.S. delegation's position at the 72nd World Health Assembly (WHA) in Geneva, Switzerland. Public Citizen testified and submitted comments, calling for the U.S. to support a transparency resolution and work towards reforms that would enhance treatment access globally. Available at https://www.citizen.org/wp-content/uploads/Comments-of-Public-Citizen-for-the-World-Health-Assembly-Stakeholder-Listening-Session-5-2-2019.pdf

  1.  On May 16, 2019, the U.S. House Committee on Oversight and Reform held a hearing to investigate Gilead Sciences' exorbitant price for the publicly funded breakthrough HIV prevention medication, Truvada. Public Citizen filed a letter for the record, with seven other organizations representing health care providers, public health experts, and consumer and taxpayer advocates. The signatories call for the Committee to recommend reforms to ensure that all Americans who need pre-exposure prophylaxis (PrEP) are able to receive it, and that the public always receives a fair return on its research and development investment. Available at: https://www.citizen.org/wp-content/uploads/Statement-on-HIV-Prevention-Drug-5-13-2019-final.pdf


Zain Rizvi
Law & Policy Researcher
Public Citizen | Protecting Health, Safety and Democracy
1600 20th St. NW, Washington, DC 20009
TEL: +1 203-508-3291
Twitter: @zainrizvi<https://twitter.com/zainrizvi>

More information about the Ip-health mailing list